• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Navigate Novartis
    • Patients
    • Healthcare Professionals
    • Media
    • Investors
    • Partners
    • ESG
    • Job Seekers
    • Clinical Trials
  • Coronavirus
  • Global
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Company
    • Our Leadership
      • Board of Directors
      • Executive Committee of Novartis
    • Our Approach
      • Strategy
      • Corporate Responsibility
      • Diversity & Inclusion
      • Partnering
      • People and Culture
    • Our Business
      • Global Product Portfolio
      • Innovative Medicines
      • Novartis Pharmaceuticals
      • Novartis Gene Therapies
      • Novartis Oncology
      • Sandoz
    • Media
      • Newsroom
      • News Archive
      • Multimedia Resources
      • Subscribe to Updates
    • Investors
      • Event Calendar
      • Financial Data
      • Share Data & Analysis
      • Shareholder Information
      • Environmental, Social & Governance
  • Our Focus
    • Disease Areas
      • Cancer
      • Cardiovascular, Renal and Metabolic Medicine
      • Immunology & Dermatology
      • Ophthalmology
      • Neuroscience
      • Respiratory
    • Platforms and Technology
      • Data and Digital
      • Cell & Gene Therapy
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
      • People and Culture
      • Live Magazine
  • Our Impact
    • Building Trust with Society
      • Corporate Responsibility
      • Ethical Standards
      • Access
      • Environmental Sustainability
    • Global Health
      • Malaria
      • Sickle Cell Disease
      • Chagas disease
      • Leprosy
      • Novartis Foundation
    • ESG Performance and Reporting
      • Materiality Assessment
      • Environmental, Social and Governance
      • Transparency and Disclosures
      • Positions on Key Topics
      • Statements on Key Issues
  • Our Science
    • Research & Early Development
      • Novartis Institutes for BioMedical Research
      • Research Disease Areas
      • Postdoc Program
      • Open Source Science
    • Drug Development at Novartis
      • Novartis Pipeline
      • Clinical Trials
      • Translational Medicine
      • Global Product Portfolio
    • Science Stories
      • Discovery
      • From Our Labs
  • Careers
    • Your Career
      • Global Career Search
      • Teams and Skills
      • Gene Therapies Careers
    • Working at Novartis
      • Diversity & Inclusion
      • People and Culture
      • Corporate Responsibility
    • Career Programs
      • Our Career Programs
      • Students and Scholars
      • Novartis Quantitative Sciences Hackathon
Search
How I built a mini-gut with next to no biology training
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
    • Whatsapp
  • Jump to Comments
Stories/From Our Labs

How I built a mini-gut with next to no biology training

By
Kaisha Benjamin
Jul 14, 2015
kaisha-1-image

A chemical engineer by training, Kaisha Benjamin recently immersed herself in the world of biology at Novartis. Image by PJ Kaszas.

kaisha-2-image

Benjamin learned to build mini-guts, which resemble flowers. Petal-like structures form as intestinal stem cells divide and differentiate. Image by Elizabeth Wiellette.

kaisha-3-image

Postdoctoral researcher Sina Mohammadi (left) taught Benjamin to passage and culture intestinal tissues. Image by PJ Kaszas.

kaisha-4-image

Mini-guts mimic the intestine in form and function. The green staining marks stem cells and the red staining marks Paneth cells, which provide a niche to support the stem cells. Image by Elizabeth Wiellette.

kaisha-5-image

Elizabeth Wiellette (middle), a lead investigator at Novartis, helped Benjamin develop her critical thinking skills, spending hours on RT-PCR data alone. Image by PJ Kaszas.

I spend a lot of time looking at mini-guts under the microscope. These models mimic our intestine in form and function, and I try to discern if they are healthy. Each one resembles a flower, with petal-like structures growing from a central sphere. These “branches” form as intestinal stem cells divide and differentiate.

Two years ago, I never imagined that I would have the opportunity to work with such a cool 3D culture system.

At the time, I had just received my undergraduate degree in chemical engineering from Howard University, and I had only a single biology course under my belt. But I knew that I wanted to transition to bioengineering. And I was up for a challenge. As Hellen Keller once said, “Life is either a daring adventure or nothing.”

I am originally from Antigua and Barbuda, a twin island nation in the eastern Caribbean. Like most children, I was inquisitive. But I never grew out of this phase. My mother deserves an award for patiently answering thousands of “what if” questions over the years. This curiosity led me to pursue a degree in science and engineering.

I was initially drawn to chemical engineering, but then I completed a summer research experience after my junior year that exposed me to the interface of engineering, biology and medicine. I found it incredibly exciting. I started researching bioengineering graduate programs and considered applying, but I learned that they require biology skills and expertise.

Luckily, I was accepted into a post-baccalaureate program run by the Novartis Institutes for BioMedical Research (NIBR) and the Massachusetts Institute of Technology (MIT) and was able to immerse myself in the world of biology. At NIBR’s headquarters in Cambridge, Mass., I’ve been able to get great hands on training. And I’ve taken genetics, biochemistry, and cell biology classes down the street at MIT. I also have a great mentor at NIBR—Elizabeth Wiellette, who is very patient with me. She has taken the time to explain a number of biological processes and pathways. And she’s helped develop my critical thinking skills. We’ve spent hours discussing how to generate and interpret graphs for RT-PCR data alone.

So how did I learn how to build mini-guts? When I first arrived, I shadowed Sina Mohammadi, a postdoc in Elizabeth’s lab, and he taught me how to passage and culture intestinal tissues. He showed me how to break apart a mini-gut and isolate single stem cell containing compartments called crypts. The crypts are plated in a gelatinous protein mixture called Matrigel that resembles the complex extracellular environment found in living tissues. Sina taught me the optimal plating density and showed me how to supplement the Matrigel with special growth factors. I monitored the cultures with him and learned to spot a healthy, branched mini-gut.

My project ultimately focused on the factors that govern intestinal stem cell identity in culture. Elizabeth’s lab has observed that intestinal stem cells behave differently, depending on their source. Stem cells from one end of the intestine express different genes than stem cells from the other end. We are trying to learn more about this specification. I conducted a compound screen (using epigenetic modulator compounds) to see if I could transform intestinal stem cell identity in culture.

I have completely evolved in my thinking and in the way that I approach scientific questions. I owe this growth and my ever increasing interest in the field of biology to Elizabeth, Sina and the training from NIBR and MIT. I recently accepted an offer to a bioengineering PhD program at Stanford, and I’m excited to start. During the grad school interview process, a professor mentioned that she thinks of her students as pluripotent stem cells, unspecialized and capable of going in many different directions. I am excited to see where the next phase of my training takes me.

Learn more about NIBR’s Gap Year Scholar Post-baccalaureate program and opportunities for recent college graduates.

Tags: 
Biomedical Research, Novartis Institutes for BioMedical Research, Scientific Research, Biomedical Science

Kaisha Benjamin

Kaisha Benjamin

is a post-baccalaureate researcher at the Novartis Institutes for BioMedical Research. She is originally from the Caribbean, and she enjoys a good game of soccer and exploring new countries and their cuisines.

    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

Coronavirus
From Our Labs

A visual tour of scientific strategies for combating coronavirus

Wendi Yajnik, Global Head of Academic Partnerships and External Innovation for research
From Our Labs

Advancing medicine through collaboration

Special instrument controlled by a production associate
From Our Labs

Turning the power of nuclear technology into a medical force

You are here

  1. Home ›
  2. Stories ›
  3. From Our Labs

Novartis Global

  • Navigate Novartis

    • Patients & Caregivers
    • Healthcare Professionals
    • Investors
    • Media
    • Society & ESG
    • Partners
  • Contact Us

    • Global Contacts
    • Office Locations
    • For Investors
    • For Media
  • About Novartis

    • Our Company
    • Our Focus
    • Our Impact
    • Our Science
    • Our Stories
  • Our Portfolio

    • Global Product Portfolio
    • Global Clinical Pipeline
  • Careers

    • Career Search

Connect with Novartis

  • twitter
  • linkedin
  • youtube
  • facebook
  • instagram
Novartis Site Directory
© 2021 Novartis AG
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map
  • Cookie Settings

This site is intended for a global audience.